Wang L, Cui J
On July 15, 2015, OMB issued OMB Bulletin No
The synthetic fragment captures the key functional sequences responsible for TB-500's regenerative properties while offering improved stability and standardized production
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Winning this recompete reflects our success, and we are eager to explore new opportunities, including the integration of artificial intelligence, in the next phase of this partnership. Over the next five years, REI will continue to innovate and improve the DSIP platform